Cardizem (diltiazem) intravenous infusion is frequently used to control rapid heart rates associated with atrial fibrillation (Afib). Remember, always follow your doctor’s specific instructions; this information is for educational purposes only and not a substitute for professional medical advice.
Dosage typically ranges from 5 to 15 mg/hour, adjusted based on the patient’s response and blood pressure. Close monitoring of heart rate and blood pressure is paramount throughout the infusion. Look for a gradual decrease in heart rate, aiming for a controlled rhythm within the therapeutic range. Hypotension is a potential side effect; be prepared to adjust the infusion rate or temporarily discontinue it if necessary.
Potential side effects beyond hypotension include nausea, dizziness, and headache. Promptly report any concerning symptoms to the medical team. Regular electrocardiogram (ECG) monitoring helps track the effectiveness of the treatment and identify any arrhythmia changes. A multidisciplinary approach, involving cardiologists and nurses, ensures optimal patient care.
Always prioritize patient safety. Understanding the drug’s mechanism of action–blocking calcium channels to slow conduction–is helpful in anticipating potential complications. This approach, combined with meticulous monitoring and prompt response to adverse events, maximizes the benefits and minimizes the risks of Cardizem drip in managing Afib.
